Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis
暂无分享,去创建一个
D. Postma | C. van Weel | T. Similowski | D. Postma | J. Derenne | C. Van herwaarden | C. V. van Schayck | J. Derenne | P. Dekhuijzen | R. Akkermans | H. Kerstjens | T. Renkema | P. D. Jong | P. V. van Grunsven | C. van Herwaarden
[1] C. P. Schayck,et al. Do patients with COPD benefit from treatment with inhaled corticosteroids? , 1996, The European respiratory journal.
[2] D. Postma,et al. Effects of long-term treatment with corticosteroids in COPD. , 1996, Chest.
[3] J C Yernault,et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.
[4] H. Kerstjens,et al. Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. , 1995, American journal of respiratory and critical care medicine.
[5] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[6] W. Bailey,et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.
[7] W. Bailey,et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .
[8] J. Bousquet,et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. , 1993, The Journal of allergy and clinical immunology.
[9] J. D. de Monchy,et al. Desensitization of the adenylyl cyclase system in peripheral blood mononuclear cells from patients with asthma three hours after allergen challenge. , 1993, The Journal of allergy and clinical immunology.
[10] A. Buist,et al. The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.
[11] D. Postma,et al. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group. , 1993, The European respiratory journal.
[12] D. Postma,et al. AIRWAYS HYPERRESPONSIVENESS, BRONCHODILATOR RESPONSE, ALLERGY AND SMOKING PREDICT IMPROVEMENT IN FEV(1) DURING LONG-TERM INHALED CORTICOSTEROID TREATMENT , 1993 .
[13] C. van Weel,et al. Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective Study , 1993, Annals of Internal Medicine.
[14] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[15] P. O'Byrne,et al. Is nedocromil sodium effective treatment for asthma? , 1993, The European respiratory journal.
[16] B. J. Smith,et al. Recent developments in the management of the pulmonary complications of HIV disease. , 1992, Thorax.
[17] D. Postma,et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. , 1992, The New England journal of medicine.
[18] N. Pride,et al. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. , 1992, Chest.
[19] D. Postma,et al. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? , 1988, The European respiratory journal.
[20] D. Postma,et al. Severe chronic airflow obstruction: can corticosteroids slow down progression? , 1985, European journal of respiratory diseases.